AMRX logo

Amneal Pharmaceuticals, Inc. (AMRX) Current assets

annual current assets:

$1.59B+$209.94M(+15.24%)
December 31, 2024

Summary

  • As of today (September 18, 2025), AMRX annual total current assets is $1.59 billion, with the most recent change of +$209.94 million (+15.24%) on December 31, 2024.
  • During the last 3 years, AMRX annual current assets has risen by +$67.70 million (+4.45%).
  • AMRX annual current assets is now at all-time high.

Performance

AMRX Current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXbalance sheet metrics

quarterly current assets:

$1.58B+$74.24M(+4.92%)
June 30, 2025

Summary

  • As of today (September 18, 2025), AMRX quarterly total current assets is $1.58 billion, with the most recent change of +$74.24 million (+4.92%) on June 30, 2025.
  • Over the past year, AMRX quarterly current assets has increased by +$99.21 million (+6.68%).
  • AMRX quarterly current assets is now -10.66% below its all-time high of $1.77 billion, reached on March 31, 2020.

Performance

AMRX quarterly current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXbalance sheet metrics

Current assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

AMRX Current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+15.2%+6.7%
3 y3 years+4.5%+2.0%
5 y5 years+31.2%+7.0%

AMRX Current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+15.2%-0.2%+21.2%
5 y5-yearat high+31.2%-0.2%+21.2%
alltimeall timeat high>+9999.0%-10.7%>+9999.0%

AMRX Current assets History

DateAnnualQuarterly
Jun 2025
-
$1.58B(+4.9%)
Mar 2025
-
$1.51B(-4.9%)
Dec 2024
$1.91B(-8.6%)
$1.59B(+4.9%)
Sep 2024
-
$1.51B(+1.9%)
Jun 2024
-
$1.49B(+7.6%)
Mar 2024
-
$1.38B(+0.2%)
Dec 2023
$2.09B(-12.3%)
$1.38B(-5.4%)
Sep 2023
-
$1.46B(+2.4%)
Jun 2023
-
$1.42B(+8.8%)
Mar 2023
-
$1.31B(-7.4%)
Dec 2022
$2.39B(-1.3%)
$1.41B(-0.6%)
Sep 2022
-
$1.42B(-8.6%)
Jun 2022
-
$1.55B(+11.8%)
Mar 2022
-
$1.39B(-8.6%)
Dec 2021
$2.42B(-1.4%)
$1.52B(-3.2%)
Sep 2021
-
$1.57B(+0.4%)
Jun 2021
-
$1.56B(+0.2%)
Mar 2021
-
$1.56B(+0.5%)
Dec 2020
$2.45B(-0.0%)
$1.55B(+0.5%)
Sep 2020
-
$1.54B(+4.2%)
Jun 2020
-
$1.48B(-16.5%)
Mar 2020
-
$1.77B(+46.6%)
Dec 2019
$2.46B(-19.9%)
$1.21B(+0.4%)
Sep 2019
-
$1.21B(+1.7%)
Jun 2019
-
$1.19B(-6.5%)
Mar 2019
-
$1.27B(-1.5%)
Dec 2018
$3.07B(+438.0%)
$1.29B(-10.1%)
Sep 2018
-
$1.43B(+6.2%)
Jun 2018
-
$1.35B(>+9900.0%)
Mar 2018
-
$0.00(-100.0%)
Dec 2017
$569.96M(-52.2%)
$771.93M(+22.3%)
Dec 2016
$1.19B(+8.3%)
-
Dec 2016
-
$631.14M(-9.9%)
Sep 2016
-
$700.59M(-9.8%)
Jun 2016
-
$776.72M(-0.7%)
Mar 2016
-
$782.37M(-4.8%)
Dec 2015
$1.10B(+214.5%)
$822.07M(+3.0%)
Sep 2015
-
$797.80M(+13.5%)
Jun 2015
-
$703.02M(+17.5%)
Mar 2015
-
$598.12M(-18.1%)
Dec 2014
$349.84M(+2.9%)
$730.45M(-2.7%)
Sep 2014
-
$751.01M(+4.4%)
Jun 2014
-
$719.55M(+10.8%)
Mar 2014
-
$649.44M(-1.6%)
Dec 2013
$339.84M(+6.7%)
$659.74M(-6.7%)
Sep 2013
-
$707.27M(+1.7%)
Jun 2013
-
$695.74M(-0.5%)
Mar 2013
-
$698.93M(+28.1%)
DateAnnualQuarterly
Dec 2012
$318.43M(+64.2%)
$545.54M(-4.0%)
Sep 2012
-
$568.50M(-7.2%)
Jun 2012
-
$612.44M(+0.7%)
Mar 2012
-
$608.43M(+1.4%)
Dec 2011
$193.92M(+8.0%)
$599.93M(+7.0%)
Sep 2011
-
$560.88M(+1.1%)
Jun 2011
-
$554.53M(+3.2%)
Mar 2011
-
$537.51M(+3.2%)
Dec 2010
$179.63M(-45.4%)
$520.69M(-3.4%)
Sep 2010
-
$539.03M(-2.8%)
Jun 2010
-
$554.77M(-0.5%)
Mar 2010
-
$557.58M(+49.1%)
Dec 2009
$329.24M(+46.0%)
$374.01M(+57.8%)
Sep 2009
-
$237.00M(+1.6%)
Jun 2009
-
$233.28M(+1.4%)
Mar 2009
-
$230.04M(-2.7%)
Dec 2008
$225.51M(+13.9%)
$236.47M(+20.4%)
Sep 2008
-
$196.32M(-25.8%)
Jun 2008
-
$264.61M(-2.2%)
Dec 2007
$198.06M(+21.4%)
$270.46M(+49.7%)
Dec 2006
$163.21M(+24.2%)
$180.67M(+20.2%)
Dec 2005
$131.40M(+69.8%)
-
Sep 2004
-
$150.30M(-5.0%)
Jun 2004
-
$158.17M(+120.1%)
Mar 2004
-
$71.88M(+30.0%)
Dec 2003
$77.41M(+1.6%)
$55.30M(+8.1%)
Sep 2003
-
$51.17M(-0.1%)
Jun 2003
-
$51.19M(+67.8%)
Mar 2003
-
$30.51M(+8.2%)
Dec 2002
$76.21M(+42.1%)
$28.19M(-16.4%)
Sep 2002
-
$33.72M(-13.8%)
Jun 2002
-
$39.10M(-3.0%)
Mar 2002
-
$40.32M(-8.3%)
Dec 2001
$53.63M(+24.7%)
$43.98M(-11.6%)
Sep 2001
-
$49.75M(-4.9%)
Jun 2001
-
$52.30M(+175.9%)
Mar 2001
-
$18.95M(-22.0%)
Dec 2000
$43.00M(-10.5%)
$24.31M(+55.0%)
Sep 2000
-
$15.69M(-30.3%)
Jun 2000
-
$22.49M(-16.5%)
Mar 2000
-
$26.93M(+97.1%)
Dec 1999
$48.04M(+750.7%)
$13.66M(+72.2%)
Sep 1999
-
$7.94M(+11.3%)
Jun 1999
-
$7.13M(+19.2%)
Mar 1999
-
$5.98M(+86.7%)
Dec 1998
$5.65M
$3.21M(+17.6%)
Sep 1998
-
$2.73M(-2.0%)
Jun 1998
-
$2.78M(-33.7%)
Mar 1998
-
$4.20M

FAQ

  • What is Amneal Pharmaceuticals, Inc. annual total current assets?
  • What is the all time high annual current assets for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. annual current assets year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. quarterly total current assets?
  • What is the all time high quarterly current assets for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. quarterly current assets year-on-year change?

What is Amneal Pharmaceuticals, Inc. annual total current assets?

The current annual current assets of AMRX is $1.59B

What is the all time high annual current assets for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high annual total current assets is $1.59B

What is Amneal Pharmaceuticals, Inc. annual current assets year-on-year change?

Over the past year, AMRX annual total current assets has changed by +$209.94M (+15.24%)

What is Amneal Pharmaceuticals, Inc. quarterly total current assets?

The current quarterly current assets of AMRX is $1.58B

What is the all time high quarterly current assets for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high quarterly total current assets is $1.77B

What is Amneal Pharmaceuticals, Inc. quarterly current assets year-on-year change?

Over the past year, AMRX quarterly total current assets has changed by +$99.21M (+6.68%)
On this page